Artificial intelligence is a facet of technology in all of our lives and may be reshaping the gaming industry as we know it. From slot machines that track your every spin to surveillance cameras that can predict a fight before it happens, AI is finding its way into nearly every corner of the gambling world.

Once a bustling casino and shopping stop for Southern Californians "who couldn't wait for Las Vegas," Primm has all but turned into a complete ghost town, according to a report from the Los Angeles Times.

Toxic fumes are leaking into airplanes, sickening crews and passengers, according to a new Wall Street Journal report. Former airline pilot Daniel Bubb discusses the issue.

Personal Perspective: The dramatic decrease in NIH grants will destroy academic science.

“I’ve been coming here since I was a kid,” said one Southern Californian as a second Primm resort announced it would cease full-time operations. The casino resorts at the California-Nevada line have been on “a slow decline,” said one expert.

Online commentary surrounding conservative activist Charlie Kirk’s assassination is now spilling into local classrooms. In the days following his death, social media posts attributed to Clark County School District (CCSD) teachers surfaced. Some teachers have been removed from classrooms, Superintendent Jhone Ebert confirmed this week.

Las Vegas loves to promote its cowboy bonafides — from Vegas Vic to our Helldorado Days and rodeo events — but how much of that is advertising, and how much of that is actual history? Was Las Vegas ever really part of the Wild West? Co-host Sarah Lohman sits down with UNLV history professor Michael Green, who explains just how much of a frontier town Vegas really was.

According to a peer-reviewed journal article published in Nature Reviews Endocrinology (2023), more than 200 million people worldwide take metformin. According to Statista (2024), close to 90 million prescriptions for metformin were recently prescribed in the United States since it was approved by the Food and Drug Administration (FDA) in 1994. This drug is the primary first-line foundational drug for the treatment of type 2 diabetes. Metformin has distinct advantages for treating type 2 diabetes because of its proven effectiveness, low risk of causing low blood sugar levels while on treatment, no adverse effects related to weight gain, a long therapeutic track record of safety, and affordability (low cost).